Tenax International S.p.A. (BIT:TNX)

Revance Therapeutics Revenue

In the year 2024, Tenax International had annual revenue of 22.57M EUR with 6.64% growth. Tenax International had revenue of 9.85M in the half year ending December 31, 2024, a decrease of -9.81%.

• Revenue: 22.57M
• Revenue Growth: +6.64%
• P/S Ratio: 0.30
• Revenue / Employee: 296.98K
• Employees: 76
• Market Cap: 6.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	22.57M	1.40M	6.64%
Dec 31, 2023	21.17M	3.56M	20.24%
Dec 31, 2022	17.60M	6.76M	62.41%
Dec 31, 2021	10.84M	2.71M	33.34%
Dec 31, 2020	8.13M	-367.54K	-4.33%